Duloxetine vs placebo in the treatment of stress urinary incontinence: a four‐continent randomized clinical trial

Abstract

These results show improvements in incontinence and quality of life with duloxetine 40 mg twice daily for 12 weeks that are in keeping with those reported in two other recently completed phase 3 trials in Europe and North America.